Department of Medicine 3 – Rheumatology and Immunology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

ESTROGEN INFLUENCES THE SIALYLATION PROFILE AND INFLAMMATORY PROPERTIES OF ANTIBODIES - A POTENTIAL EXPLANATION FOR THE SEX DIFFERENCES AND INCREASED RISK FOR RA IN POSTMENOPAUSAL WOMEN (2017) Engdahl C, Raufer J, Harre U, Bondt A, Pfeifle R, Krönke G, Scherer HU, et al. Conference contribution EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS (2017) Bergmann C, Brandt A, Dees C, Wohlfahrt T, Zhang Y, Chen CW, Mallano T, et al. Conference contribution IMATINIB-LOADED TARGETED GOLD NANOPARTICLES AMELIORATE EXPERIMENTAL LUNG FIBROSIS INDUCED BY BLEOMYCIN (2017) Codullo V, Breda S, Meloni F, Cova E, Inghilleri S, Colombo M, Prosperi D, et al. Conference contribution EVALUATION OF FREQUENCY AND TYPE OF PHYSICAL THERAPY IN MORE THAN 3400 PATIENTS WITH SYSTEMIC SCLEROSIS (2017) Belz D, Moinzadeh P, Blank N, Siegert E, Henes J, Worm M, Sunderkoetter C, et al. Conference contribution IL-17-22-23 PATHWAYS IN PSORIATIC ARTHRITIS AND PSORIASIS (2017) Nas K, Cevik R, Yildiz I, Rech J, Schett G Conference contribution Influence of Swiprosin2/EFhd1 on the metabolic control of B cell differentiation and humoral immunity (2017) Urbanczyk S, Stein MF, Duetting S, Mougiakakos D, Boesl M, Reimer D, Steinmetz T, et al. Conference contribution DIFFERENTIAL SCAVENGING OF APOPTOTIC CELLS AND BACTERIA (2017) Kronke G Conference contribution ABATACEPT BUT NOT TNF INHIBITORS BLOCK AUTOANTIBODY-MEDIATED CYTOKINE PRODUCTION BY MONOCYTES (2017) Bozec A, Luo Y, Engdahl C, Figueiredo C, Bang H, Schett G Conference contribution APREMILAST TREATMENT AND LONG-TERM (UP TO 156 WEEKS) IMPROVEMENTS IN DACTYLITIS AND ENTHESITIS IN PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSIS OF A LARGE DATABASE OF THE PHASE III CLINICAL DEVELOPMENT PROGRAM (2017) Gladman DD, Kavanaugh A, Gomez-Reino JJ, Wollenhaupt J, Cutolo M, Schett G, Lespessailles E, et al. Conference contribution DURABILITY OF APREMILAST RESPONSE IN PATIENTS WITH PSORIATIC ARTHRITIS: LONG-TERM (208-WEEK) RESULTS FROM THE PALACE 1 TRIAL (2017) Kavanaugh A, Gladman DD, Gomez-Reino JJ, Hall S, Lespessailles E, Mease PJ, Schett G, et al. Conference contribution